Connection

Juan Horcajada to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Juan Horcajada has written about Treatment Outcome.
Juan Horcajada
Connection Strength
0.127
Treatment Outcome
  1. Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical. J Infect. 2019 09; 79(3):253-261.
    View in: PubMed
    Score: 0.030
  2. Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients? Molecules. 2019 Feb 01; 24(3).
    View in: PubMed
    Score: 0.029
  3. High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections. Med Clin (Barc). 2017 09 08; 149(5):223-224.
    View in: PubMed
    Score: 0.026
  4. Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa. BMC Infect Dis. 2017 01 05; 17(1):11.
    View in: PubMed
    Score: 0.025
  5. Azithromycin in the treatment of COVID-19: a review. Expert Rev Anti Infect Ther. 2021 02; 19(2):147-163.
    View in: PubMed
    Score: 0.008
  6. Invasive aspergillosis in kidney transplant recipients: a cohort study. Exp Clin Transplant. 2014 Apr; 12(2):101-5.
    View in: PubMed
    Score: 0.005
  7. Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study. BMC Infect Dis. 2012 Oct 05; 12:245.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.